Sljedeći

Auto Play

Miles Prince, MD, explains the outcomes of the ALCANZA study in CD30-expressing CTCL

4 Pogledi • 08/09/23
Udio
Ugraditi
administrator
administrator
Pretplatnici
0

Dr. Prince, Professor, The University of Melbourne and Monash University, talks about the outcomes of the ALCANZA study in CD30-expressing CTCL

Prikaži više
0 Komentari sort Poredaj po
Komentari na Facebooku

Sljedeći

Auto Play